We Venture Capital
Description
Early stage diagnostics investor
Investor Profile
We Venture Capital has made 4 investments, with 2 in the past 12 months and 75% as lead.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- United Kingdom (50%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (25%)
- Sweden (25%)
Industry Focus
- Health Care
- Biotechnology
- Health Diagnostics
- Medical
- Medical Device
- Life Science
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
